- OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
- Co-Diagnostics Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
- Philips and Mass General Brigham: Advancing Patient Care
- Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
- The Importance of Deburring in Modern Manufacturing | By Brett Mandes, LISSMAC Corporation
- MG America Named Exclusive North American Distributor for Two Prominent Pharma Equipment Manufacturers
- Suj Mehta Elevates TekniPlex Healthcare as New CEO
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
Medovate Signs First Distributor Agreement for its Pioneering SAFIRA® Technology in the Veterinary Field with 20/20 Imaging in the USA
Bob Salzman, President 20/20 Imaging said: “This is a ground-breaking new technology for safer regional anesthesia and is unique in making it a one person procedure and reducing reliance on subjective ‘injection pressure feel’. 20/20 Imaging are proud to be the first appointed distributor to be bringing its unique benefits to the veterinary market and we look forward to making this exciting technology available to veterinary professionals across America alongside our leading range of ultrasound solutions to enable them to deliver the best care for their patients.”
Relievant Medsystems Announces Favorable Coverage Policy from Cigna Healthcare for the Intracept Procedure
“This positive coverage determination from Cigna Healthcare, one of the country’s leading health benefit providers, is vastly impactful in increasing patient and physician access to our proven treatment for vertebrogenic pain,” said Tyler Binney, President and CEO of Relievant Medsystems.
NIOX® Group Celebrates 25 Years of Innovation in FeNO Testing for Asthma
Since its foundation, the company has worked to help improve asthma care with its ground-breaking FeNO testing devices. With almost 50 million tests performed worldwide, NIOX® continues to lead the development of FeNO for patient care.
The Importance Of Dosing Pumps In The Laboratory
Dosing pumps are crucial linchpins in any modern laboratory. They’re mechanical workhorses, ensuring accurate and consistent delivery of various fluids. Their importance is underscored by
Clinical Trials
DermaSensor’s Non-Invasive Skin Cancer Device Found to Halve the Number of Skin Cancers Not Referred by PCPs
Of the two studies presented, one demonstrated the standalone performance of the hand-held, non-invasive device, and the other evaluated the impact of the device on PCPs’ management of skin cancer.
Stanford Spinoff PhysioWave Announces Clinical Study with Omron Healthcare
The PhysioWave Pro™ scale measures the stiffness of the major blood vessel into which the heart pumps, the aorta. Stiffness increases with age, but excess stiffness among people of similar ages can be a warning sign of risk. It is established that increased vascular stiffness can predict the later development of high blood pressure, or hypertension, and a higher risk of cardiovascular disease.
MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA
SFA SELUTION4SFA is being conducted in over 30 centers in the US plus an additional 10 centers worldwide. The study will enroll 300 patients, with the aim of demonstrating the superiority of SELUTION SLR over balloon angioplasty (POBA). The primary efficacy endpoint is primary patency of the target lesion at 12 months and the primary safety endpoint is freedom from death at 30 days. Enrollment into the study will be complete by the end of 2023.
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Digital Pathology Reaches an Inflection Point as AI Targets Workflow Gaps | By Yair Rivenson, PhD Founder and CEO, Pictor Labs
Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
FIZE Medical Launches 5,000-Patient Retrospective Study to Further Establish the benefits of using FIZE kUO in managing ICU patients’ Hemodynamic status
By continuously capturing renal function patterns, the study aims to demonstrate how FIZE kUO® can provide data for early signs of instability that are often missed by intermittent measurements
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Market Reports